Myelosuppression and "conventional" chemotherapy: what price, what benefit?
Canellos
G P
GP
Demetri
G D
GD
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001855:Bone Marrow Diseases / Q000139:chemically induced / Q000517:prevention & control*; D003365:Costs and Cost Analysis; D016298:Hematopoietic Cell Growth Factors / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D011788:Quality of Life; D016019:Survival Analysis
D000970:Antineoplastic Agents; D016298:Hematopoietic Cell Growth Factors